Skip to content

Stock markets in Europe exhibiting minimal fluctuations, in anticipation of the upcoming US interest rate decision

In connection with the Federal Reserve's interest rate decision, there was minimal fluctuation in major European stock markets, as influential economic data from the US was unveiled the day prior.

Stock markets in Europe display minimal activity, ahead of the anticipated US interest rate...
Stock markets in Europe display minimal activity, ahead of the anticipated US interest rate announcement

Stock markets in Europe exhibiting minimal fluctuations, in anticipation of the upcoming US interest rate decision

In the world of finance, September seems to be off to a volatile start, with the stock market showing signs of indecision after weeks of lethargy.

One of the most notable developments is the anticipated interest rate cutting cycle by the Federal Reserve, which could potentially stimulate economic growth.

The stock market, however, has seen its fair share of losses, with energy and commodity stocks among the biggest casualties. This downturn can be attributed to a variety of factors, including concerns about a potential disruption in Russian oil supplies, which previously boosted oil prices. As a result, oil prices eased, ending their winning streak.

Despite this, the tech sector has remained in demand across Europe.

In the "Footsie", the British FTSE 100, Marks & Spencer's shares gained over four percent. This surge can be linked to monthly data from NielsenIQ, which showed an acceleration in Marks & Spencer's sales growth in the food sector.

SAP also saw a rise of 3.2 percent, a development that Jefferies analyst Charles Brennan expects to be a turnaround in the company's performance.

Meanwhile, the EuroStoxx 50 closed at 5,369.70 points, while the Swiss SMI closed at 11,998.96 points.

In the pharmaceutical sector, Novo Nordisk's shares rose nearly three percent in Copenhagen. The company, under the leadership of its new CEO, Maziar Mike Doustdar, has undergone significant restructuring, including layoffs of 9,000 employees worldwide. This restructuring is aimed at cutting costs and refocusing the company’s growth strategy.

Despite the challenges, Berenberg's analysis suggests that Novo Nordisk's new CEO has the opportunity to positively surprise. In fact, Berenberg has issued a buy recommendation for Novo Nordisk's shares.

The US dollar and the euro are also making headlines, with the US dollar jumping to a four-year high above 1.18 dollars, according to market strategist Jürgen Molnar from the trading house Robomarkets.

As the month progresses, it will be interesting to see how these trends and developments unfold in the global financial landscape.

Read also:

Latest